Organogenesis is a pioneer and commercial leader in regenerative medicine. We are focused in the areas of bioactive wound healing and soft tissue regeneration.
We empower clinicians with the full range of products and tools they need to heal their patients and to achieve better health outcomes.
From our headquarters on a four-building campus in Massachusetts, to our locations in Alabama, California, Florida and Switzerland, our 900 employees work together towards empowering healing.
Our mission is to provide an integrated porfolio of healing solutions that improve lives while lowering the overall cost of health care. We are relentless in the pursuit of quality and innovations that make all the difference.
Initially, our corporate mission was to “introduce regenerative medicine to the world.” With over 1 million units of Apligraf® and Dermagraft® (the world’s leading regenerative medicine products) shipped for patient use, we believe that we have successfully achieved this objective.
Across the organization, our mission guides our actions. We strive to build products and services that integrate the benefits of regenerative medicine into the everyday practice of medicine.